Biomanufacturing@MIT-CBI

Biomanufacturing@MIT-CBI

Biomanufacturing@MIT-CBI

Biomanufacturing
@MIT-CBI

We advance technology, training, and knowledge networks in biomanufacturing with the overarching goals of safe, timely, and efficient production and delivery of biologic medicines.

We advance technology, training, and knowledge networks in biomanufacturing with the overarching goals of safe, timely, and efficient production and delivery of biologic medicines.

We advance technology, training, and knowledge networks in biomanufacturing with the overarching goals of safe, timely, and efficient production and delivery of biologic medicines.

COLLABORATION

Biomanufacturing@MIT-CBI is home to the Biomanufacturing Consortium (BioMAN), the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB), and BioACCESS. These pre-competitive programs provide a safe haven where industry, academia, and government collaboratively address challenges in manufacturing, delivery, and access to biologics through focused events and projects that address key challenges in biomanufacturing.

RESEARCH

Biomanufacturing@MIT-CBI research projects focus on biomanufacturing process innovation for production of biologic medicines including monoclonal antibodies, vaccines, viral vectors, and cell therapies. Our main research areas include process analytical technologies, biomanufacturing data analytics, advanced process modeling and control, and continuous manufacturing.

EDUCATION

Biomanufacturing@MIT-CBI has developed a number of biomanufacturing-related educational offerings including a residential MIT course, an on-line course on the principles of manufacturing protein and antibody drugs, and a short course on vaccine manufacturing offered jointly with University College London. We are co-developing a blended learning course for the training of cell therapy manufacturing personnel which will combine online learning with hands-on training.

LATEST NEWS & RESEARCH

BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.

BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.

BioACCESS took part in consultations and reviewed the IAVI Welcome report, which sets out a roadmap to make lifesaving antibody…
BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations

BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations

CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first webinar…
Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies

Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies

This report, made possible through the efforts of our consortium members, offers lessons learned to help prevent viruses from contaminating…

UPCOMING EVENTS

No event found!